139 related articles for article (PubMed ID: 34335603)
1. Site-Specific Glycan-Masking/Unmasking Hemagglutinin Antigen Design to Elicit Broadly Neutralizing and Stem-Binding Antibodies Against Highly Pathogenic Avian Influenza H5N1 Virus Infections.
Chen TH; Yang YL; Jan JT; Chen CC; Wu SC
Front Immunol; 2021; 12():692700. PubMed ID: 34335603
[TBL] [Abstract][Full Text] [Related]
2. Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses.
Li H; Sun H; Tao M; Han Q; Yu H; Li J; Lu X; Tong Q; Pu J; Sun Y; Liu L; Liu J; Sun H
J Virol; 2024 Mar; 98(3):e0112923. PubMed ID: 38305155
[TBL] [Abstract][Full Text] [Related]
3. Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses.
Nuñez IA; Ross TM
Vaccine; 2020 Jan; 38(4):830-839. PubMed ID: 31733946
[TBL] [Abstract][Full Text] [Related]
4. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses.
Zhou F; Wang G; Buchy P; Cai Z; Chen H; Chen Z; Cheng G; Wan XF; Deubel V; Zhou P
J Virol; 2012 Jun; 86(12):6970-8. PubMed ID: 22496212
[TBL] [Abstract][Full Text] [Related]
5. Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus.
Furey C; Scher G; Ye N; Kercher L; DeBeauchamp J; Crumpton JC; Jeevan T; Patton C; Franks J; Rubrum A; Alameh MG; Fan SHY; Phan AT; Hunter CA; Webby RJ; Weissman D; Hensley SE
Nat Commun; 2024 May; 15(1):4350. PubMed ID: 38782954
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus.
Santiago FW; Fitzgerald T; Treanor JJ; Topham DJ
Vaccine; 2011 Nov; 29(48):8888-97. PubMed ID: 21963871
[TBL] [Abstract][Full Text] [Related]
7. Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.
Yang P; Duan Y; Zhang P; Li Z; Wang C; Dong M; Tang C; Xing L; Gu H; Zhao Z; Liu X; Zhang S; Wang X
PLoS One; 2012; 7(1):e30252. PubMed ID: 22279575
[TBL] [Abstract][Full Text] [Related]
8. Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.
Isakova-Sivak I; Chen LM; Bourgeois M; Matsuoka Y; Voeten JT; Heldens JG; van den Bosch H; Klimov A; Rudenko L; Cox NJ; Donis RO
Clin Vaccine Immunol; 2014 May; 21(5):722-31. PubMed ID: 24648485
[TBL] [Abstract][Full Text] [Related]
9. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.
Ge J; Deng G; Wen Z; Tian G; Wang Y; Shi J; Wang X; Li Y; Hu S; Jiang Y; Yang C; Yu K; Bu Z; Chen H
J Virol; 2007 Jan; 81(1):150-8. PubMed ID: 17050610
[TBL] [Abstract][Full Text] [Related]
10. A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.
Hu H; Voss J; Zhang G; Buchy P; Zuo T; Wang L; Wang F; Zhou F; Wang G; Tsai C; Calder L; Gamblin SJ; Zhang L; Deubel V; Zhou B; Skehel JJ; Zhou P
J Virol; 2012 Mar; 86(6):2978-89. PubMed ID: 22238297
[TBL] [Abstract][Full Text] [Related]
11. Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines.
Giles BM; Bissel SJ; Dealmeida DR; Wiley CA; Ross TM
Clin Vaccine Immunol; 2012 Feb; 19(2):128-39. PubMed ID: 22190399
[TBL] [Abstract][Full Text] [Related]
12. Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses.
Wang S; Hackett A; Jia N; Zhang C; Zhang L; Parker C; Zhou A; Li J; Cao WC; Huang Z; Li Y; Lu S
PLoS One; 2011; 6(12):e28757. PubMed ID: 22205966
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.
Prabakaran M; Madhan S; Prabhu N; Qiang J; Kwang J
J Virol; 2010 Apr; 84(7):3201-9. PubMed ID: 20071572
[TBL] [Abstract][Full Text] [Related]
14. Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine.
Bar-Peled Y; Huang J; Nuñez IA; Pierce SR; Ecker JW; Ross TM; Mousa JJ
Vaccine; 2019 Sep; 37(41):6022-6029. PubMed ID: 31481254
[TBL] [Abstract][Full Text] [Related]
15. Identification of specific neutralizing antibodies for highly pathogenic avian influenza H5 2.3.4.4b clades to facilitate vaccine design and therapeutics.
Tuan Duong B; Ju Yeo S; Park H
Emerg Microbes Infect; 2024 Dec; 13(1):2302106. PubMed ID: 38170506
[TBL] [Abstract][Full Text] [Related]
16. Lineage-specific epitope profiles for HPAI H5 pre-pandemic vaccine selection and evaluation.
Qiu X; Duvvuri VR; Gubbay JB; Webby RJ; Kayali G; Bahl J
Influenza Other Respir Viruses; 2017 Sep; 11(5):445-456. PubMed ID: 28715148
[TBL] [Abstract][Full Text] [Related]
17. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses.
Moin SM; Boyington JC; Boyoglu-Barnum S; Gillespie RA; Cerutti G; Cheung CS; Cagigi A; Gallagher JR; Brand J; Prabhakaran M; Tsybovsky Y; Stephens T; Fisher BE; Creanga A; Ataca S; Rawi R; Corbett KS; Crank MC; Karlsson Hedestam GB; Gorman J; McDermott AB; Harris AK; Zhou T; Kwong PD; Shapiro L; Mascola JR; Graham BS; Kanekiyo M
Immunity; 2022 Dec; 55(12):2405-2418.e7. PubMed ID: 36356572
[TBL] [Abstract][Full Text] [Related]
18. Evidence of exposure of domestic pigs to Highly Pathogenic Avian Influenza H5N1 in Nigeria.
Meseko C; Globig A; Ijomanta J; Joannis T; Nwosuh C; Shamaki D; Harder T; Hoffman D; Pohlmann A; Beer M; Mettenleiter T; Starick E
Sci Rep; 2018 Apr; 8(1):5900. PubMed ID: 29651056
[TBL] [Abstract][Full Text] [Related]
19. Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.
Rijal P; Wang BB; Tan TK; Schimanski L; Janesch P; Dong T; McCauley JW; Daniels RS; Townsend AR; Huang KA
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748388
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.
Karron RA; Talaat K; Luke C; Callahan K; Thumar B; Dilorenzo S; McAuliffe J; Schappell E; Suguitan A; Mills K; Chen G; Lamirande E; Coelingh K; Jin H; Murphy BR; Kemble G; Subbarao K
Vaccine; 2009 Aug; 27(36):4953-60. PubMed ID: 19540952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
